Cargando…
Development and testing of a random forest-based machine learning model for predicting events among breast cancer patients with a poor response to neoadjuvant chemotherapy
BACKGROUND: Breast cancer (BC) is the most common malignant tumor around the world. Timely detection of the tumor progression after treatment could improve the survival outcome of patients. This study aimed to develop machine learning models to predict events (defined as either (1) the first tumor r...
Autores principales: | Jin, Yudi, Lan, Ailin, Dai, Yuran, Jiang, Linshan, Liu, Shengchun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543332/ https://www.ncbi.nlm.nih.gov/pubmed/37777809 http://dx.doi.org/10.1186/s40001-023-01361-7 |
Ejemplares similares
-
Association of serum reproductive hormones changes after neoadjuvant chemotherapy with hormone receptors expression alterations and survival outcomes in breast cancer
por: Lan, Ailin, et al.
Publicado: (2022) -
Development and Assessment of a Novel Core Biopsy-Based Prediction Model for Pathological Complete Response to Neoadjuvant Chemotherapy in Women with Breast Cancer
por: Lan, Ailin, et al.
Publicado: (2023) -
Comparison of the pCR Rate and DFS Among Breast Cancer Patients with Different Hormone Receptor and HER2 Statuses
por: Jin, Yudi, et al.
Publicado: (2023) -
Nomograms for Predicting Disease-Free Survival Based on Core Needle Biopsy and Surgical Specimens in Female Breast Cancer Patients with Non-Pathological Complete Response to Neoadjuvant Chemotherapy
por: Lan, Ailin, et al.
Publicado: (2023) -
Plasma fibrinogen acts as a predictive factor for pathological complete response to neoadjuvant chemotherapy in breast cancer: a retrospective study of 1004 Chinese breast cancer patients
por: Wang, Yihua, et al.
Publicado: (2021)